Founders Capital Management (Texas)’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.9K | Hold |
|
|||||
|
2025
Q1 | $5.42K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $13.6K | Buy |
|
|||||
|
2024
Q2 | $7.98K | Hold |
|
|||||
|
2024
Q1 | $11.8K | Hold |
|
|||||
|
2023
Q4 | $8.72K | Hold |
|
|||||
|
2023
Q3 | $9.44K | Hold |
|
|||||
|
2023
Q2 | $11.3K | Hold |
|
|||||
|
2023
Q1 | $12K | Hold |
|
|||||
|
2022
Q4 | $9K | Hold |
|
|||||
|
2022
Q3 | $9K | Hold |
|
|||||
|
2022
Q2 | $13K | Hold |
|
|||||
|
2022
Q1 | $20K | Hold |
|
|||||
|
2021
Q4 | $20K | Buy |
|
|||||
|
2021
Q3 | $13K | Hold |
|
|||||
|
2021
Q2 | $14K | Hold |
|
|||||
|
2021
Q1 | $12K | Hold |
|
|||||
|
2020
Q4 | $9K | Buy |
|
|||||
|
2020
Q1 | $4K | Hold |
|
|||||
|
2019
Q4 | $4K | Hold |
|
|||||
|
2019
Q3 | $5K | Hold |
|
|||||
|
2019
Q2 | $5K | Hold |
|
|||||
|
2019
Q1 | $7K | Buy |
|